As America celebrates its 250th birthday, it’s worth pausing to recognize one of our nation’s greatest achievements: a legacy ...

Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: The State of the Biopharmaceutical Industry 2025" report has been added to ResearchAndMarkets.com's offering. The research report ...

With biosimilars being an everyday headline, Jason Bernstein, Epocrates Lead Strategist, outlined key reasons for pharma's growing interest in biosimilar development and key differences between ...

Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2023" report has been added to ResearchAndMarkets.com's offering. This report examines the business environment ...

Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals. The current biopharmaceutical industry is estimated at more than $400 billion/year revenue and continues to ...

Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment. Without question, biopharmaceutical manufacturing has changed dramatically since 1977, ...

The biopharmaceutical industry faces strict regulations worldwide, making it essential to meet international standards before any new therapy can enter the market. Staying informed about the current ...

The biopharmaceutical sector has experienced a revival in mergers and acquisitions in the second half of the year. I see three primary reasons for this uptick in deal-making intensity: patent ...

According to a new Frost and Sullivan report, “Preparing for Next Generation of Biopharmaceutical Manufacturing,” the bioindustry industry is facing “its biggest test in recent times” due to new ...

London: The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative ...

The past three years have been interesting times for the biopharmaceutical industry. The first biosimilar product—Omnitrope (recombinant human growth hormone (rhGH); Sandoz, Holzkirchen, Germany) for ...